CANCER: THE SCIENCE, THE EVIDENCE, AND THE CLAIMS ABOUT DETOXIFICATION
I've been hearing claims that cancer is essentially a buildup of toxic material in the body and that all you need is the right concoction to help your body drain it away. This idea is sometimes associated with what's called terrain theory.
Rather than simply arguing opinions, I want to share scientific resources, educational videos, university lectures, TED Talks, and oncology textbooks that explain what cancer is, how it develops, and whether detoxification has been shown to cure it.
My goal is to encourage people to examine the evidence and draw informed conclusions.
━━━━━━━━━━━━━━━━━━
PART 1: WHAT IS CANCER, REALLY?
━━━━━━━━━━━━━━━━━━
Cancer is not simply a collection of waste products. It develops when cells acquire changes that allow them to grow abnormally, evade normal biological controls, and sometimes invade surrounding tissues or spread to distant organs.
Tumors are living biological structures containing cancer cells, blood vessels, immune cells, connective tissue, and other components that interact with one another.
1. National Cancer Institute — What Is Cancer?
https://www.cancer.gov/about-cancer/understanding/what-is-cancer
2. National Cancer Institute — Defining Cancer (video)
https://www.cancer.gov/about-cancer/understanding/what-is-cancer/defining-cancer-video
3. National Cancer Institute — Inside a Tumor (video resources)
https://www.cancer.gov/multimedia-0
4. TED-Ed — How Do Cancer Cells Behave Differently From Healthy Ones?
https://ed.ted.com/lessons/how-do-cancer-cells-behave-differently-from-healthy-ones
These resources explain the biological reality of cancer and show that a tumor is much more complex than a collection of toxins.
━━━━━━━━━━━━━━━━━━
PART 2: CANCER CAN SPREAD THROUGHOUT THE BODY
━━━━━━━━━━━━━━━━━━
Malignant cancer cells can invade surrounding tissues, enter the bloodstream or lymphatic system, and establish tumors in other organs. This process is called metastasis.
That is fundamentally different from having a collection of toxins that can simply be flushed out of the body.
5. National Cancer Institute — How Cancer Spreads (video)
https://www.cancer.gov/types/metastatic-cancer/how-cancer-spreads-video
6. National Cancer Institute — The Immune System and Cancer (video)
https://www.cancer.gov/about-cancer/understanding/what-is-cancer/immune-system-and-cancer-video
7. TED-Ed — How Does Cancer Spread Through the Body?
https://www.youtube.com/watch?v=OcigJn8UJNQ
8. TED-Ed — Why Is It So Hard to Cure Cancer?
https://www.youtube.com/watch?v=h2rR77VsF5c
These resources explain how cancer spreads and why different cancers can require different approaches to treatment.
━━━━━━━━━━━━━━━━━━
PART 3: UNIVERSITY-LEVEL CANCER BIOLOGY LECTURES
━━━━━━━━━━━━━━━━━━
If you want to hear university instructors explain cancer biology in greater depth, these are excellent places to start.
9. MIT OpenCourseWare — Lecture 25: Cancer 1
https://ocw.mit.edu/courses/7-016-introductory-biology-fall-2018/resources/lecture-25-cancer-1/
An undergraduate biology lecture explaining how normal cellular controls break down and how cancer develops.
10. MIT OpenCourseWare — Lecture 26: Cancer 2
https://ocw.mit.edu/courses/7-016-introductory-biology-fall-2018/resources/lecture-26-cancer-2/
Continues with cancer biology, including processes that allow malignant cells to invade tissues and spread.
11. MIT OpenCourseWare — Lecture 20: Cancer
https://ocw.mit.edu/courses/7-012-introduction-to-biology-fall-2004/resources/lecture-20-cancer/
An additional university lecture examining the mechanisms involved in cancer development.
12. MIT OpenCourseWare — Cancer Biology Lectures 29–31
https://ocw.mit.edu/courses/7-013-introductory-biology-spring-2013/pages/video-lectures/
A series of cancer biology lectures from MIT's introductory biology course.
13. Johns Hopkins University — Introduction to the Biology of Cancer
https://www.coursera.org/learn/cancer
A structured university course covering cancer genetics, the hallmarks of cancer, metastasis, diagnosis, and treatment. Access to course materials may depend on the current enrollment options.
14. University of Illinois Cancer Center — Cancer Biology Educational Videos
https://cancer.uillinois.edu/videos-increasing-scientific-literacy/
An educational resource for learning about cancer biology and the science behind cancer research.
15. The Ohio State University — Introduction to Cancer Concepts: Solid Tumors
https://u.osu.edu/cancerforteachers/1-what-is-cancer/1-2-solid-tumors/
An educational resource explaining solid tumors and their biological characteristics.
These university resources explain the mechanisms of cancer rather than relying on opinions, anecdotes, or marketing claims.
━━━━━━━━━━━━━━━━━━
PART 4: TED TALKS ABOUT CANCER
━━━━━━━━━━━━━━━━━━
16. Mina Bissell — Experiments That Point to a New Understanding of Cancer
https://www.ted.com/talks/mina_bissell_experiments_that_point_to_a_new_understanding_of_cancer
A particularly relevant talk about how the tissue surrounding a cell influences cancer development and behavior. It acknowledges that the cellular environment matters without claiming that cancer is simply toxins that can be drained away.
17. Hasini Jayatilaka — How Cancer Cells Communicate, and How We Can Slow Them Down
Explores how cancer cells communicate and interact with their surroundings.
18. William Li — Can We Eat to Starve Cancer?
https://ed.ted.com/lessons/can-we-eat-to-starve-cancer-william-li/digdeeper
Discusses angiogenesis, the process through which tumors develop blood vessels. Nutrition is relevant to cancer biology, but this talk should not be interpreted as proof that particular foods cure existing cancer.
19. TED-Ed — How to Biohack Your Cells to Fight Cancer
https://ed.ted.com/lessons/how-to-biohack-your-cells-to-fight-cancer-greg-foot
Explains how scientists can engineer immune cells to help fight cancer, including CAR T-cell therapy.
━━━━━━━━━━━━━━━━━━
PART 5: OTHER CANCER EDUCATION VIDEOS
━━━━━━━━━━━━━━━━━━
20. TED-Ed — The Cancer Gene We All Have
https://www.youtube.com/watch?v=pOyKFgGKmHE
Explores the role of genes involved in regulating cell growth and how their disruption can contribute to cancer.
21. National Cancer Institute — Cancer Education and Video Resources
https://www.cancer.gov/multimedia-0
A broader collection of cancer education resources covering cancer biology, prevention, diagnosis, and treatment.
━━━━━━━━━━━━━━━━━━
PART 6: DOES THE BODY'S INTERNAL ENVIRONMENT MATTER?
━━━━━━━━━━━━━━━━━━
Absolutely!
The immune system, inflammation, metabolism, hormones, genetics, environmental exposures, and the tissue surrounding a tumor can all influence cancer development and progression.
Science recognizes the importance of the environment in which cells exist. But acknowledging that the body's environment matters does not establish that cancer is merely accumulated waste or that detoxification can cure it.
22. National Cancer Institute — Causes of Cancer
https://www.cancer.gov/research/areas/causes
23. Peer-reviewed scientific review — Tissue Architecture, Genetics, Epigenetics, and Cell Metabolism in Carcinogenesis
https://pubmed.ncbi.nlm.nih.gov/37268024/
This review discusses different models of cancer development, including genetics, epigenetics, tissue organization, and cell metabolism.
Science continues to investigate how these mechanisms interact. That is not evidence that cancer is waste material that can be drained away.
━━━━━━━━━━━━━━━━━━
PART 7: ONCOLOGY TEXTBOOKS AND MEDICAL REFERENCES
━━━━━━━━━━━━━━━━━━
For anyone who wants to go beyond videos and read the material used in medical and university education, these books and references are worth exploring.
24. Understanding Cancer — National Institutes of Health
https://www.ncbi.nlm.nih.gov/books/NBK20362/
An introductory educational resource covering cancer development, cell division, tumors, and metastasis.
25. Holland-Frei Cancer Medicine — NCBI Bookshelf
https://www.ncbi.nlm.nih.gov/books/NBK20777/toc/?report=reader
A comprehensive oncology reference covering cancer biology, genetics, tumor immunology, causes, pathology, and treatment. The online edition is old, so its foundational biology is useful, but its clinical treatment information should not be treated as current guidance.
26. Molecular Biology of the Cell — Cancer Chapter
https://www.ncbi.nlm.nih.gov/books/NBK21076/
A foundational molecular biology textbook resource relevant to understanding cancer at the cellular level. Access to the full chapter may be limited.
27. Introduction to Cancer Concepts — University of Massachusetts Medical School
https://publishing.escholarship.umassmed.edu/plugins/books/1/format/15/download/
An educational guidebook introducing cancer concepts for medical students and other learners.
28. The Biology of Cancer — Robert A. Weinberg
https://www.routledge.com/The-Biology-of-Cancer/Weinberg/p/book/9780815342205
A major university-level textbook covering oncogenes, tumor-suppressor genes, cell signaling, tumor development, and metastasis. Full access may require purchase or a library subscription.
29. Introduction to Cancer Biology — Robin Hesketh
A textbook covering cancer risk factors, DNA mutations, cell signaling, tumor development, and the molecular basis of cancer.
30. Oxford Textbook of Cancer Biology
https://academic.oup.com/book/24948
An advanced academic reference covering the biological foundations of cancer and mechanisms of tumor progression.
31. Oncology at a Glance — Wiley
https://onlinelibrary.wiley.com/doi/book/10.1002/9781394292721
An illustrated introduction to cancer biology, diagnosis, treatment, and clinical oncology.
━━━━━━━━━━━━━━━━━━
PART 8: WHAT DOES THE EVIDENCE SAY ABOUT DETOXES AND ALTERNATIVE CANCER CURES?
━━━━━━━━━━━━━━━━━━
There is a difference between supporting general health and actually treating cancer.
A supplement, cleanse, juice regimen, herbal concoction, or special diet cannot be assumed to eliminate malignant cells just because someone claims it removes toxins.
If a product is advertised as a cancer cure, where are the controlled human clinical trials demonstrating that it eliminates tumors, prevents recurrence, or improves survival?
32. National Center for Complementary and Integrative Health — Cancer and Complementary Health Approaches
https://www.nccih.nih.gov/health/cancer-and-complementary-health-approaches-what-you-need-to-know
Explains what is known about complementary approaches and why they should not be confused with proven cancer treatments.
33. American Cancer Society — Diet, Physical Activity, and Cancer
Discusses the evidence about diet, lifestyle, and cancer risk, helping distinguish general health advice from claims that a diet or cleanse cures an existing cancer.
34. Cancer Research UK — Alternative Cancer Diets
Examines alternative dietary approaches promoted for cancer and the evidence supporting or contradicting their claims.
━━━━━━━━━━━━━━━━━━
PART 9: WHAT WOULD ACTUALLY PROVE THAT A DETOX CONCOCTION CURES CANCER?
━━━━━━━━━━━━━━━━━━
We should ask for:
Controlled clinical trials involving human patients.
Objective measurements of tumors before and after treatment.
Evidence that the cancer has disappeared or been controlled, not simply that the patient feels better.
Long-term follow-up to determine whether the cancer returns.
Evidence of improved survival and an honest assessment of adverse effects.
Independent studies reproducing the results.
A testimonial is not a controlled clinical trial. A theory about toxins is not proof of a cure. And a substance killing cancer cells in a laboratory does not automatically mean it safely treats cancer in a human being.
HERE IS THE BOTTOM LINE
I'm not arguing that the body's environment is irrelevant. It clearly matters. I'm not arguing that science knows everything about cancer, either. Research continues to uncover new mechanisms and improve treatment.
I'm asking for evidence that supports the specific claim being made.
If someone says cancer is nothing more than toxins that can be drained away, they need to demonstrate that claim with reliable evidence. The burden of proof belongs to the person claiming to have a cure.
Cancer is a complex disease involving living cells and their interactions with the body. Treating it requires more than assuming that a detoxification process will solve the problem.
Question everything—including conventional medicine—but apply the same standard of evidence to every proposed treatment.
And please don't delay evidence-based cancer care in favor of an unproven cleanse or concoction.
If anyone has credible, reproducible clinical evidence that a particular detox product cures cancer, I'm willing to examine it. That's how science should work.
Yes—breast cancer and prostate cancer are two of the clearest examples of major progress in cancer survival. But they aren't the only ones. Leukemia, melanoma, lung cancer, and several other cancers have also seen important advances, including treatments that have transformed diseases that were once much harder to control.
The strongest evidence comes from looking at both survival rates and cancer death rates over time, rather than simply counting how many people live after diagnosis. The National Cancer Institute and the American Association for Cancer Research publish data documenting these trends.
1. Cancers that have made major strides
1. Breast cancer
The five-year relative survival rate for women with breast cancer is about 92% in recent U.S. data. Progress has come from mammography, earlier diagnosis, improved surgery and radiation, hormone therapies, targeted drugs, and treatments tailored to tumor characteristics. Breast cancer mortality fell about 44% from 1989 to 2024.
2. Prostate cancer
The five-year relative survival rate is approximately 98%. PSA testing, surgery, radiation, hormone therapies, and newer targeted treatments have contributed to improved outcomes. However, survival is much lower for some cancers that have already spread to distant organs.
3. Chronic myeloid leukemia (CML)
One of the most striking examples of progress through targeted treatment. Drugs such as imatinib target a specific abnormal protein that drives the cancer. Five-year relative survival rose from approximately 22% in the mid-1970s to 71% for people diagnosed during 2016–2022.
4. Melanoma
Immunotherapy and targeted drugs have substantially improved outcomes, including for some patients whose melanoma has spread. Survival for distant-stage melanoma has more than doubled since the mid-1990s.
5. Multiple myeloma
This cancer of plasma cells in the bone marrow has benefited from new drug combinations, immune-based treatments, and other therapies. Five-year relative survival increased from approximately 32% in the mid-1990s to 64% during 2016–2022.
6. Lung cancer
Historically one of the deadliest cancers, lung cancer has seen progress from reduced smoking, earlier detection in eligible people, targeted drugs, and immunotherapy. The lung cancer death rate fell an average of 4.7% per year among men from 2019–2023, according to the Annual Report to the Nation.
7. Childhood acute lymphoblastic leukemia (ALL)
ALL is a powerful example of progress through decades of clinical research, combination chemotherapy, improved supportive care, and newer targeted and immune therapies for selected patients. Most children with ALL now survive, although outcomes vary by disease subtype and risk factors.
2. The bigger picture: cancer mortality has declined
United States · 1991–2024
35%
Decline in the overall cancer death rate, translating to an estimated 4.8 million cancer deaths averted.
Source: American Association for Cancer Research, Cancer Progress Report 2026.
This is one of the most useful statistics for your discussion. It reflects progress across many cancer types, driven by a combination of prevention, screening, diagnosis, and treatment. It does not mean every cancer is becoming easier to treat.
3. The important scientific caveat
Survival statistics need to be interpreted carefully. A high five-year survival rate doesn't automatically mean a treatment has cured that percentage of patients. Screening can detect cancers earlier, and some slow-growing cancers might never have caused serious harm. These factors can increase measured survival without producing an equivalent reduction in deaths.
That's why falling cancer death rates are especially important evidence of real progress. Researchers examine mortality alongside survival, stage at diagnosis, and treatment outcomes to understand what is improving.
For your discussion about detoxification, the strongest point is this: cancer outcomes have improved as researchers have identified specific mechanisms of disease and developed treatments that act on those mechanisms. The progress in CML, for example, followed the development of a drug targeting a specific cancer-driving protein.
That doesn't prove every conventional treatment works or that science has answered every question about cancer. It does show that understanding cancer biology has led to measurable improvements in patient outcomes.
For a source you can share with your group, I'd recommend the AACR Cancer Progress Report 2026. It brings together survival improvements, mortality trends, and examples of how research has translated into better treatments.
This might also interest you.
There is some truth behind those discussions, but they often leave out the most important part: the risks of screening are real, but that doesn't mean the risks outweigh the benefits. The balance depends on the test, a person's age and health, family history, and whether the test is being used for routine screening or to investigate symptoms.
Mammograms and colonoscopies also have different risk profiles. Mammograms use low-dose X-rays and can lead to false alarms or unnecessary treatment. Colonoscopies are more invasive and carry a small risk of bleeding, bowel perforation, and complications from sedation. Both can also find abnormalities that would never have caused serious harm.
The fair question isn't whether screening has any risk. It is whether the harms are greater than the benefits for the particular group being screened.
1. Mammograms: what are the real risks?
The U.S. Preventive Services Task Force (USPSTF) recommends a mammogram every two years for women ages 40–74 who are at average risk. It concludes that the benefits outweigh the harms for this group, with moderate certainty.
Here are the main concerns, with the evidence behind them.
Concern | What the evidence says |
|---|---|
False positives | A mammogram can look suspicious when no cancer is present, leading to repeat imaging or biopsy. |
Overdiagnosis | Some cancers found would never have caused symptoms or shortened a person's life. We cannot reliably identify every such case in advance. |
Radiation | Mammograms use ionizing radiation, but the dose is low and the estimated cancer risk from routine screening is very small. |
Unnecessary treatment | Overdiagnosed cancers may lead to surgery, radiation, or medication that ultimately provides no benefit. |
Missed cancers | Mammograms do not find every cancer, especially in some people with dense breast tissue. A normal result does not rule out cancer if symptoms develop. |
These are recognized medical concerns, not made-up objections. The National Cancer Institute discusses them directly in its breast cancer screening evidence review.
What about the balance of benefits and harms?
The NCI summarizes modeling used to inform the 2024 screening recommendations. For every 1,000 women screened every two years from ages 40 through 74, the models estimate approximately:
8.2 breast cancer deaths prevented
1,376 false-positive results over the screening period
201 biopsies following screening
14 overdiagnosed breast cancers
These are modeled lifetime totals, not results from a single screening round. A false-positive result is not the same as a cancer diagnosis, and the same person can have more than one false positive. The numbers also represent estimates, not guaranteed outcomes.
The important interpretation: screening can save lives, but it also causes harm for some people. Whether that trade-off is worthwhile depends partly on age, individual risk, and personal preferences.
2. Colonoscopies: are the risks greater than the benefits?
For most average-risk adults ages 45–75, the evidence says no. The USPSTF concludes that colorectal cancer screening has a substantial net benefit for ages 50–75 and a moderate net benefit for ages 45–49. Screening after age 75 is a more individualized decision.
The risk is real, though. A colonoscopy can cause bleeding, a tear or perforation in the bowel wall, or complications from sedation. The risk increases with age and is higher when polyps are removed.
The USPSTF evidence review estimates the following rates:
Serious complications per 10,000 colonoscopies
Routine screening colonoscopy
Major bleeding
14.6
Bowel perforation
3.1
Colonoscopy following a positive stool screening test
Serious bleeding
17.5
Bowel perforation
5.4
Source: USPSTF evidence review. These are estimated rates, not predictions for an individual. The categories are separate and should not simply be added together.
Those numbers show that serious complications are uncommon, but not nonexistent. They also don't capture every inconvenience or harm, such as the unpleasant bowel preparation, time off work, anxiety, or the cost of follow-up.
One major difference between mammograms and colonoscopies
A colonoscopy can do something especially valuable: remove precancerous polyps during the same procedure. Some polyps would eventually become cancer, although not all do. Removing them can prevent certain cancers from developing in the first place.
And a colonoscopy is not the only screening option. For average-risk adults, options include:
FIT stool test: usually once a year; checks for hidden blood.
Stool DNA-FIT test: checks for blood and certain DNA markers, usually every one to three years depending on the test and guidance.
Colonoscopy: generally every 10 years if results are normal and the person remains at average risk.
A positive stool test needs follow-up colonoscopy. A stool test avoids the immediate risks of colonoscopy for people whose results are negative, but it does not allow a doctor to remove polyps, and it can miss cancers.
3. Copy-and-paste sources for your discussion
Here are reliable sources you can share directly. I've included the full URLs so they can be copied into a post or comment.
4. How I would evaluate the claims you are seeing
A few questions help separate a legitimate criticism from a misleading argument:
Does it compare actual outcomes? A study showing that screening causes false positives does not, by itself, establish that screening causes more harm than benefit.
Does it distinguish screening from diagnosis? Screening is for people without symptoms. Someone with a breast lump, blood in the stool, or other concerning symptoms may need diagnostic testing regardless of routine screening recommendations.
Does it account for age and baseline risk? The balance can change substantially with age, family history, prior screening, and overall health.
Does it confuse overdiagnosis with false diagnosis? Overdiagnosis means a genuine cancer is found that would not have caused harm during the person's lifetime. It is not the same as a false-positive test.
Does it compare screening with the alternative? The alternative is not always “no harm.” It may be a cancer discovered later, when it is harder to treat.
Copy-and-paste sources:
American Association for Cancer Research — Cancer in 2026:
https://cancerprogressreport.aacr.org/progress/cpr26-contents/cpr26-cancer-in-2026/
National Cancer Institute — Colorectal cancer statistics:
https://seer.cancer.gov/statfacts/html/colorect.html
American Cancer Society — Colorectal cancer survival rates:
https://www.cancer.org/cancer/types/colon-rectal-cancer/detection-diagnosis-staging/survival-rates.html
National Cancer Institute — Colorectal cancer screening:
https://www.cancer.gov/types/colorectal/screening-fact-sheet
U.S. Preventive Services Task Force — Breast cancer screening recommendation:
https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening
National Cancer Institute — Breast cancer screening, benefits and harms:
https://www.cancer.gov/types/breast/hp/breast-screening-pdq
National Cancer Institute — Breast cancer screening information:
https://www.cancer.gov/types/breast/screening
American Cancer Society — Limitations of mammograms:
https://www.cancer.org/cancer/types/breast-cancer/screening-tests-and-early-detection/mammograms/limitations-of-mammograms.html
U.S. Preventive Services Task Force — Colorectal cancer screening recommendation:
https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening
National Cancer Institute — Colorectal cancer screening fact sheet:
https://www.cancer.gov/types/colorectal/screening-fact-sheet
National Cancer Institute — Colorectal cancer screening:
https://www.cancer.gov/types/colorectal/patient/colorectal-screening-pdq
U.S. Preventive Services Task Force — Colorectal screening evidence summary:
https://www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary19/colorectal-cancer-screening
FINAL CONCLUSION
There are legitimate scientific debates about how often to screen, when to begin or stop screening, how to reduce false positives, and how to avoid unnecessary diagnosis and treatment. The risks of screening should never be dismissed.
However, the broad claim that mammograms and colonoscopies are generally more dangerous than beneficial does not reflect the conclusions of the major evidence reviews for the populations in which routine screening is recommended.
Mammography can reduce breast cancer mortality, while colorectal cancer screening can detect cancer earlier and, in the case of colonoscopy, prevent some cancers by removing precancerous polyps.
The most defensible position is neither “screening is harmless” nor “screening is a scam.” It is that screening has measurable benefits and measurable harms, and recommendations should be based on the best available evidence about the balance between them.
This also connects to the larger discussion about detoxification claims. The fact that medical screening has limitations does not provide evidence that cancer is simply a buildup of toxins that can be flushed out. Cancer involves abnormal cell growth, genetic and molecular changes, interactions with surrounding tissue, and other biological processes. A criticism of one medical intervention is not proof that an alternative treatment works.
The appropriate questions are: What does the proposed treatment do? Has it been tested in well-designed studies? Does it prevent cancer, shrink tumors, extend life, or improve quality of life? What are its harms? And are the results reproducible?
Those standards should apply equally to conventional medicine and to claims about detoxification or alternative cancer treatments.
ADDENDUM: WHY HAVEN’T WE CURED CANCER? ADDRESSING A COMMON MISCONCEPTION
Original question and observation
I often hear the statement:
“Over a hundred years of cancer research and billions of dollars spent, and we still have no cure for cancer!”
I find this frustrating because it treats cancer as though it were one disease. The statement also seems to ignore the advances that researchers have made in preventing, diagnosing, treating, and sometimes curing different cancers.
Is there a podcast or reliable scientific source that addresses this argument directly? Why is cancer so difficult to cure, and is it accurate to say that cancer research has failed because there is no universal cure?
1. Cancer is not one disease
The first problem with the statement is that it treats the word cancer as if it describes a single disease with one cause, one biological mechanism, and one treatment.
It does not.
The National Cancer Institute explains that there are more than 100 types of cancer. These diseases can differ in the tissues where they originate, the genetic changes that drive their growth, the speed at which they progress, and their responses to treatment. Even cancers that begin in the same organ can have substantially different biological characteristics.
Cancer also develops from our own cells. As cells accumulate changes that affect growth, survival, and other functions, some acquire the ability to grow uncontrollably and invade or spread to other tissues. Different tumors can acquire different combinations of changes.
This creates a fundamental challenge: a treatment that works well against one cancer may do little against another. Even within a single patient's tumor, cancer cells may differ, and some may survive treatment and eventually become the source of recurrence.
The scientific goal is therefore not simply to discover one drug that cures “cancer.” It is to understand the different diseases grouped under that name and develop ways to prevent, detect, treat, and, where possible, cure each of them.
Primary scientific source — National Cancer Institute: What Is Cancer?
Copy-and-paste URL:
https://www.cancer.gov/about-cancer/understanding/what-is-cancer
2. A podcast that directly addresses the “Why haven't we cured cancer?” argument
One particularly relevant resource is That Cancer Conversation, a podcast produced by Cancer Research UK.
Podcast: “Why Haven't We Cured Cancer?”
The episode brings together perspectives from cancer history, clinical oncology, and cancer research. It examines why the search for a cure is more complicated than the public often assumes.
Topics include:
Why cancer has been recognized for thousands of years, but effective modern treatments developed much more recently.
Why cancer comprises hundreds of different diseases rather than one uniform condition.
How tumors evolve and change over time.
Why some cancers develop resistance to treatment.
Why preventing cancer and detecting it early are important forms of progress, even when they do not produce a dramatic new cure.
Why helping people live longer and maintain a good quality of life can be a meaningful treatment success, even when a cancer cannot be eliminated completely.
One particularly important point is that the word cure can mean different things in different contexts. A cancer that disappears following treatment and never returns is different from one that remains controlled for years with ongoing treatment. Both outcomes matter, but they should not be confused.
The podcast also discusses the history of cancer research and how scientific priorities, cultural expectations, and funding decisions influence which questions researchers pursue.
Listen to the podcast here:
https://news.cancerresearchuk.org/2022/06/14/why-havent-we-cured-cancer-that-cancer-conversation/
Read the full transcript here:
https://news.cancerresearchuk.org/why-havent-we-cured-cancer-podcast-transcript/
These are useful sources to share because they address the question directly rather than simply providing a list of successful cancer treatments.
3. Is there really no cure for cancer?
No. Saying that there is no universal cure for every cancer is not the same as saying that no cancers can be cured.
Some cancers have high cure rates with appropriate treatment. Others can be controlled for long periods. Still others remain difficult to treat, especially after they have spread or developed resistance to available therapies.
For example, testicular cancer is highly treatable, and many cases can be cured. Certain leukemias have also seen major improvements from treatments directed at specific molecular abnormalities. Other cancers, including some advanced pancreatic and brain cancers, remain much more challenging.
These differences are precisely why broad statements about “the cancer cure” are misleading.
Cancer Research UK addresses this distinction in its explainer, “Science Surgery: Will cancer ever be cured?” It explains that cancer is an umbrella term for hundreds of diseases and that many cancers can already be cured, even though a single treatment that eliminates every cancer is unlikely.
Source — Cancer Research UK: Science Surgery: Will Cancer Ever Be Cured?
Copy-and-paste URL:
https://news.cancerresearchuk.org/2017/09/21/science-surgery-will-cancer-ever-be-cured/
The important qualification is that cure rates vary considerably by cancer type, stage, and other individual factors. It would be just as inaccurate to claim that cancer research has solved the problem as it would be to claim that research has achieved nothing.
4. What counts as progress if a universal cure has not been found?
The slogan that cancer research has failed often relies on a narrow definition of success: either every cancer has been cured, or nothing meaningful has been accomplished.
That is not how scientific or medical progress should be evaluated.
Progress can include:
Prevention. Reducing exposure to cancer-causing substances, preventing certain infections through vaccination, and identifying people at increased risk can prevent some cancers from developing.
Early detection. Screening can identify certain cancers at earlier stages, when treatment is more likely to be successful. Some screening methods can also prevent cancer by identifying and removing precancerous changes.
Cures. Some cancers can be eliminated through surgery, radiation, medication, or combinations of treatments.
Longer survival. Treatments can help people live longer, including people whose cancer cannot currently be cured.
Better-targeted treatment. Molecular testing can identify changes in a tumor that make certain therapies more likely to work. This can allow treatment decisions to be based on the characteristics of a cancer rather than only the organ in which it began.
Improved quality of life. Better symptom management, supportive care, and treatments with fewer or more manageable side effects can help patients maintain daily activities and spend more time with loved ones.
Reduced recurrence and treatment resistance. Research into tumor evolution helps scientists understand why cancers return or stop responding to a treatment and how those problems might be overcome.
These are not interchangeable outcomes, and none means that every cancer has become easy to treat. But they are all legitimate measures of progress.
The National Cancer Institute explains how cancer-associated genetic changes contribute to tumor behavior and how scientists use this knowledge to develop treatments targeting particular molecular abnormalities.
Source:
https://www.cancer.gov/about-cancer/understanding/what-is-cancer
5. Why can cancer return after treatment?
This is another reason that a universal cure is so difficult.
A tumor is not necessarily a perfectly uniform collection of identical cells. Different cells within a tumor may have different genetic changes and characteristics. A treatment may destroy most of the cancer cells while leaving a small population capable of surviving.
Those surviving cells may eventually multiply, producing a recurrence. In other cases, the cancer may evolve changes that make it less sensitive or resistant to a treatment that previously worked.
This is not unique to one particular cancer, and it does not mean that treatment was pointless. It means that cancer biology can be dynamic rather than static.
Researchers study these changes to understand which tumors are likely to respond to a treatment, why resistance develops, and whether combinations or sequences of treatments can improve outcomes.
The Cancer Research UK podcast discusses this challenge through research into cancer evolution and drug resistance.
Podcast and transcript:
https://news.cancerresearchuk.org/2022/06/14/why-havent-we-cured-cancer-that-cancer-conversation/
https://news.cancerresearchuk.org/why-havent-we-cured-cancer-podcast-transcript/
6. A related issue: claims about miracle cures and detoxification
This discussion matters when evaluating claims that cancer can be cured by detoxification, supplements, extreme diets, or other treatments promoted as alternatives to conventional cancer care.
The fact that cancer research has not produced one cure for every cancer does not establish that a detoxification treatment works. Nor does dissatisfaction with the cost, side effects, or limitations of conventional treatment constitute evidence that an alternative treatment is effective.
Those claims need to be evaluated separately, using evidence from appropriately designed studies. We need to ask whether the proposed treatment has been shown to improve meaningful outcomes, such as survival, tumor response, recurrence, or quality of life, and whether its risks have been assessed.
It is reasonable to question pharmaceutical companies, research funding, conflicts of interest, treatment costs, and unequal access to care. Scientific medicine should be open to scrutiny. But the same standards of evidence must apply to conventional treatments and alternative claims.
Anecdotes and testimonials can generate questions, but they cannot reliably establish that a treatment caused a recovery. A person may have received conventional treatment at the same time, experienced an unusually favorable course of disease, or misunderstood what a diagnosis or scan showed.
A useful related podcast is “Can You Trust Cancer Advice Online?” from Cancer Research UK. It addresses online cancer advice and claims about purported miracle treatments.
Copy-and-paste URL:
The appropriate question is not whether an approach is labeled natural, conventional, alternative, or experimental. The question is whether reliable evidence demonstrates that it is safe and effective for the particular cancer and clinical situation.
7. A more meaningful way to ask the question
Instead of asking only, “Why haven't we cured cancer?” more productive questions include:
Which cancers can we now cure, and how have those outcomes changed?
Which cancers can we prevent or detect early?
Which treatments have improved survival or quality of life?
Why do some cancers resist treatment or return?
Which cancers remain especially difficult to treat, and why?
How can research funding, clinical trials, and access to treatment be improved?
What evidence supports a claimed alternative treatment, and how does it compare with established care?
These questions acknowledge both sides of the reality: cancer research has made substantial advances, and important problems remain.
Conclusion
The statement “Over a hundred years of cancer research and billions of dollars spent, and still no cure for cancer” is misleading because it treats the absence of one universal cure as evidence that medical research has failed.
Cancer is not one disease. It is a broad group of diseases with different biological causes, behaviors, and treatment responses. Some can be cured in many patients; others can be controlled for extended periods; and some remain devastatingly difficult to treat.
None of this means that research funding should be immune from criticism or that every treatment is effective. It means that progress should be judged by the evidence: which cancers are prevented, which patients are cured, how long people live, how well they live, and what remains to be solved.
The absence of one cure for every cancer is not evidence that cancer research has failed. It is evidence that the problem is more complex than the slogan acknowledges.
The best starting point for readers who want to explore this argument further is the Cancer Research UK podcast, followed by the National Cancer Institute's explanation of cancer biology.
Copy-and-paste reference list
National Cancer Institute — What Is Cancer?
https://www.cancer.gov/about-cancer/understanding/what-is-cancerCancer Research UK — Why Haven't We Cured Cancer? podcast
https://news.cancerresearchuk.org/2022/06/14/why-havent-we-cured-cancer-that-cancer-conversation/Cancer Research UK — full podcast transcript
https://news.cancerresearchuk.org/why-havent-we-cured-cancer-podcast-transcript/Cancer Research UK — Science Surgery: Will Cancer Ever Be Cured?
https://news.cancerresearchuk.org/2017/09/21/science-surgery-will-cancer-ever-be-cured/Cancer Research UK — Can You Trust Cancer Advice Online? podcast
https://news.cancerresearchuk.org/2026/04/02/can-you-trust-cancer-advice-online-that-cancer-conversation-season-4-ep-7/
No comments:
Post a Comment